LDLRAD3 can engage distinct signaling pathways to enhance the protein's activity. Forskolin is a diterpene that directly stimulates adenylyl cyclase, causing an upsurge in intracellular cAMP levels, which in turn activates Protein Kinase A (PKA). Activated PKA can then phosphorylate LDLRAD3, resulting in its activation. Similarly, IBMX, by inhibiting phosphodiesterases, prevents the breakdown of cAMP, leading to sustained PKA activation and subsequent phosphorylation and activation of LDLRAD3. Isoproterenol, a synthetic compound functioning as a beta-adrenergic agonist, also elevates intracellular cAMP, thereby activating PKA, which can then target LDLRAD3. Another agent, Prostaglandin E2 (PGE2), interacts with its G-protein coupled receptors, which may result in increased cAMP and activation of LDLRAD3 through PKA signaling. Anisomycin, although known primarily as a protein synthesis inhibitor, also functions as an activator of the JNK signaling pathway. The activation of JNK can influence other kinases or transcription factors that can phosphorylate and activate LDLRAD3.
The activation of LDLRAD3 can also be influenced by other chemicals that affect intracellular signaling cascades. For instance, Ionomycin raises intracellular calcium levels and can activate calcium-dependent kinases, which in turn may activate LDLRAD3. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of Protein Kinase C (PKC), which can phosphorylate and activate LDLRAD3. Retinoic acid, involved in regulating gene expression, can alter cellular pathways leading to LDLRAD3 activation. Epidermal Growth Factor (EGF) binds to its receptor and initiates a cascade involving MAPK/ERK pathways, culminating in the activation of LDLRAD3. Lithium chloride, a GSK-3 inhibitor, can activate the Wnt signaling pathway, which might result in the activation of LDLRAD3. Lastly, Sodium fluoride activates various enzymes, potentially leading to phosphorylation events that activate LDLRAD3. These chemicals, through their respective pathways, ensure the phosphorylation and activation of LDLRAD3, modulating its activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases leading to an increase in cAMP levels, supporting PKA activation and subsequent activation of LDLRAD3 through phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, elevates intracellular cAMP, thereby activating PKA that can phosphorylate and activate LDLRAD3. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) binds to its G-protein coupled receptors, potentially causing increases in cAMP, which can activate LDLRAD3 through PKA signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 inhibitor, resulting in increased cAMP levels which can activate PKA and enhance the phosphorylation of LDLRAD3. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a JNK activator; JNK pathway activation can lead to modulation of intracellular signaling cascades that activate LDLRAD3. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, which can activate calcium-dependent protein kinases that subsequently activate LDLRAD3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could then phosphorylate and activate LDLRAD3 via downstream signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate cellular differentiation and proliferation pathways, which can lead to the activation of LDLRAD3 as part of signal transduction. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, potentially leading to the activation of Wnt signaling and subsequent activation of LDLRAD3. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride can activate various intracellular enzymes and pathways, potentially leading to the phosphorylation and activation of LDLRAD3. | ||||||